abiraterone has been researched along with isoconazole in 1 studies
| Studies (abiraterone) | Trials (abiraterone) | Recent Studies (post-2010) (abiraterone) | Studies (isoconazole) | Trials (isoconazole) | Recent Studies (post-2010) (isoconazole) |
|---|---|---|---|---|---|
| 942 | 97 | 854 | 117 | 15 | 26 |
| Protein | Taxonomy | abiraterone (IC50) | isoconazole (IC50) |
|---|---|---|---|
| Heme oxygenase 1 | Rattus norvegicus (Norway rat) | 5.6 | |
| Heme oxygenase 2 | Rattus norvegicus (Norway rat) | 5.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodie, AM; Clement, OO; Freeman, CM; Handratta, VD; Hartmann, RW; Njar, VC; Vasaitis, TS | 1 |
1 other study(ies) available for abiraterone and isoconazole
| Article | Year |
|---|---|
Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy.
Topics: Algorithms; Antineoplastic Agents; Azoles; Binding Sites; Enzyme Inhibitors; Humans; Hydrogen Bonding; Male; Models, Molecular; Prostatic Neoplasms; Protein Binding; Quantitative Structure-Activity Relationship; Steroid 17-alpha-Hydroxylase; Steroids | 2003 |